DK168705B1 - Methylendioxyphenanthren- og stilbenderivater og farmaceutisk acceptable salte deraf, fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende methylendioxyphenanthren- og stilbenderivater eller farmaceutisk acceptable salte der af - Google Patents

Methylendioxyphenanthren- og stilbenderivater og farmaceutisk acceptable salte deraf, fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende methylendioxyphenanthren- og stilbenderivater eller farmaceutisk acceptable salte der af Download PDF

Info

Publication number
DK168705B1
DK168705B1 DK407586A DK407586A DK168705B1 DK 168705 B1 DK168705 B1 DK 168705B1 DK 407586 A DK407586 A DK 407586A DK 407586 A DK407586 A DK 407586A DK 168705 B1 DK168705 B1 DK 168705B1
Authority
DK
Denmark
Prior art keywords
formula
pharmaceutically acceptable
acceptable salts
converted
methylenedioxyphenanthrene
Prior art date
Application number
DK407586A
Other languages
Danish (da)
English (en)
Other versions
DK407586D0 (da
DK407586A (da
Inventor
Klaus Goerler
Guenter Krumbiegel
Michael Hanack
Lakshmina R Subramanian
Original Assignee
Madaus Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus Ag filed Critical Madaus Ag
Publication of DK407586D0 publication Critical patent/DK407586D0/da
Publication of DK407586A publication Critical patent/DK407586A/da
Application granted granted Critical
Publication of DK168705B1 publication Critical patent/DK168705B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK407586A 1985-08-28 1986-08-27 Methylendioxyphenanthren- og stilbenderivater og farmaceutisk acceptable salte deraf, fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende methylendioxyphenanthren- og stilbenderivater eller farmaceutisk acceptable salte der af DK168705B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19853530718 DE3530718A1 (de) 1985-08-28 1985-08-28 Methylendioxyphenanthren- und -stilbenderivate, verfahren zur herstellung derselben und arzneimittel, die diese enthalten
DE3530718 1985-08-28

Publications (3)

Publication Number Publication Date
DK407586D0 DK407586D0 (da) 1986-08-27
DK407586A DK407586A (da) 1987-03-01
DK168705B1 true DK168705B1 (da) 1994-05-24

Family

ID=6279566

Family Applications (1)

Application Number Title Priority Date Filing Date
DK407586A DK168705B1 (da) 1985-08-28 1986-08-27 Methylendioxyphenanthren- og stilbenderivater og farmaceutisk acceptable salte deraf, fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende methylendioxyphenanthren- og stilbenderivater eller farmaceutisk acceptable salte der af

Country Status (27)

Country Link
US (2) US4835178A (sv)
JP (1) JPS62167776A (sv)
KR (1) KR880000179B1 (sv)
AR (1) AR242568A1 (sv)
AT (1) AT398568B (sv)
BE (1) BE905340A (sv)
CH (1) CH673457A5 (sv)
DD (1) DD266800A5 (sv)
DE (1) DE3530718A1 (sv)
DK (1) DK168705B1 (sv)
ES (1) ES2001893A6 (sv)
FI (1) FI92396C (sv)
FR (1) FR2586681B1 (sv)
GB (1) GB2179347B (sv)
HU (3) HU895304D0 (sv)
IE (1) IE59239B1 (sv)
IT (1) IT1197467B (sv)
LU (1) LU86556A1 (sv)
MX (2) MX172917B (sv)
NL (1) NL8602127A (sv)
NO (1) NO863434L (sv)
PL (2) PL154026B1 (sv)
PT (1) PT83258B (sv)
SE (1) SE465153B (sv)
SU (1) SU1731053A3 (sv)
YU (2) YU44061B (sv)
ZA (1) ZA866487B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0432983A3 (en) * 1989-12-15 1991-08-21 Pharma Mar, S.A. Novel compounds of the diterpene type
EP0498095B1 (en) * 1991-02-05 1995-01-04 Merrell Dow Pharmaceuticals Inc. Sulfonic stilbene derivatives in the treatment of viral diseases
WO1993016992A1 (en) * 1992-02-20 1993-09-02 Merrell Dow Pharmaceuticals Inc. Sulfonic acid derivatives in the treatment of viral diseases
US5334615A (en) * 1992-12-17 1994-08-02 Walles Wilhelm E Oil with bactericidal and virucidal properties
US5739166A (en) * 1994-11-29 1998-04-14 G.D. Searle & Co. Substituted terphenyl compounds for the treatment of inflammation
CN112778264B (zh) * 2021-01-21 2023-09-15 江西农业大学 马兜铃次酸衍生物及其在制备抗炎药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4122092A (en) * 1977-08-25 1978-10-24 University Of Rochester Total synthesis of (±)-picropodophyllone and (±)-4'-demethylpicropodophyllone
JPS57106677A (en) * 1980-12-22 1982-07-02 Kureha Chem Ind Co Ltd N-(3,4-methylenedioxybenzylidene) aminomethylcyclohexane-carboxylic acid, and salt of said carboxylic acid

Also Published As

Publication number Publication date
HUT44775A (en) 1988-04-28
DK407586D0 (da) 1986-08-27
FI92396B (sv) 1994-07-29
GB2179347B (en) 1989-08-09
IE862288L (en) 1987-02-28
FR2586681A1 (fr) 1987-03-06
SE8603589D0 (sv) 1986-08-26
PL148757B1 (en) 1989-11-30
AR242568A1 (es) 1993-04-30
NO863434L (no) 1987-03-02
IT8621526A0 (it) 1986-08-26
YU44061B (en) 1990-02-28
MX3550A (es) 1993-10-01
US4835178A (en) 1989-05-30
FI863282A0 (sv) 1986-08-13
IE59239B1 (en) 1994-01-26
SU1731053A3 (ru) 1992-04-30
KR880000179B1 (ko) 1988-03-12
PL261196A1 (en) 1988-02-04
FI863282A (sv) 1987-03-01
IT1197467B (it) 1988-11-30
PT83258B (pt) 1988-07-01
JPS62167776A (ja) 1987-07-24
DE3530718C2 (sv) 1992-07-09
KR870002119A (ko) 1987-03-30
YU147586A (en) 1988-02-29
DK407586A (da) 1987-03-01
LU86556A1 (fr) 1986-12-02
BE905340A (fr) 1987-02-27
ZA866487B (en) 1987-04-29
HU199446B (en) 1990-02-28
DE3530718A1 (de) 1987-03-12
HU202104B (en) 1991-02-28
YU43998B (en) 1990-02-28
GB8619644D0 (en) 1986-09-24
JPH0349908B2 (sv) 1991-07-31
AT398568B (de) 1994-12-27
FI92396C (sv) 1994-11-10
YU114987A (en) 1988-02-29
PT83258A (de) 1986-09-01
US5024743A (en) 1991-06-18
PL154026B1 (en) 1991-06-28
NO863434D0 (no) 1986-08-27
MX172917B (es) 1994-01-21
GB2179347A (en) 1987-03-04
SE8603589L (sv) 1987-03-01
SE465153B (sv) 1991-08-05
HU895304D0 (en) 1990-03-28
MX9300436A (es) 1994-07-29
PL268178A1 (en) 1988-10-13
DD266800A5 (de) 1989-04-12
NL8602127A (nl) 1987-03-16
CH673457A5 (sv) 1990-03-15
ES2001893A6 (es) 1988-07-01
ATA215186A (de) 1994-05-15
FR2586681B1 (fr) 1991-02-22

Similar Documents

Publication Publication Date Title
JP2950616B2 (ja) トリテルペン誘導体
JP2000502708A (ja) ビトロネクチン受容体拮抗物質
JPS6212795A (ja) 新規なプソラレン誘導体
CA2130859A1 (en) Thienopyrimidine derivatives, their production and use
JP2724114B2 (ja) トリテルペン誘導体およびそれを含有するエンドセリンレセプター拮抗剤
DK168705B1 (da) Methylendioxyphenanthren- og stilbenderivater og farmaceutisk acceptable salte deraf, fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende methylendioxyphenanthren- og stilbenderivater eller farmaceutisk acceptable salte der af
PL125321B1 (en) Process for preparing novel,condensed derivatives of pyrimidines
FR2537584A1 (fr) Pyrazoloquinoleines substituees particulieres, procede pour leur preparation, preparations pharmaceutiques contenant ces composes et leur application therapeutique
KR890001425B1 (ko) 피리도 [2,3-d] 피리미딘-5-온류 및 그의 제법
JP4156795B2 (ja) アミノアルカンスルホン酸、ホスホン酸およびホスフィン酸の新たな誘導体、それらの製造、並びに薬物としてのそれらの使用
DK155663B (da) Analogifremgangsmaade til fremstilling af n-oe6-(fluorsubstitueret phenoxy)-5-indanylaa-methansulfonamidderivater
EP1005347A1 (en) Macrophage scavenger receptor antagonists for use in the treatment of cardiovascular diseases
CA2416537A1 (en) Calcilytic compounds
JPH01268689A (ja) 新規なベンゾイミダゾ〔１，２―ｃ〕キナゾリン、その製造及び用途
EP1383511A2 (en) Calcilytic compounds
JPS59204167A (ja) ヒドロキノン誘導体およびその製法
JPH0667880B2 (ja) ｇｅｍ−ジハロ−１，８−ジアミノ−４−アザ−オクタン類
CA3089666A1 (en) Ghrelin o-acyltransferase inhibitors
FI63396C (fi) Foerfarande foer framstaellning av pao gallavsoendringen verkande /2-isopropyl-4-(2-tenoyl-5-metyl/-fenoxiaettiksyra
EP0094059B1 (en) Novel aminonaphthacene derivatives and process for preparation thereof
NO175635B (sv)
NO174808B (no) Fremgangsmåte for fremstilling av terapeutisk aktive metylendioksyfenantren-derivater
JPS61236779A (ja) ３環式化合物
JPS6097976A (ja) ６Ｈ‐ジベンズ〔ｂ，ｆ〕チエピン化合物
JPH072828A (ja) キサントン誘導体、およびその製造法ならびに使用法

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed